Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?

Perner, Anders; Venkatesh, Balasubramanian

Perner, Anders; Venkatesh, Balasubramanian.

Perner A; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark. Electronic address: anders.perner@regionh.dk.
Venkatesh B; Department of Intensive Care, The Wesley Hospital, Brisbane, QLD, Australia; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.

Lancet ; 401(10387): 1474-1476, 2023 05 06.

Article in English | MEDLINE | ID: covidwho-2301734

Subject(s)

COVID-19; Respiration Disorders; Humans; COVID-19 Drug Treatment; Hypoxia/etiology; Dexamethasone/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiration Disorders / COVID-19 Type of study: Etiology study Limits: Humans Language: English Journal: Lancet Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google